Abstract

The report by Krishna MT and colleagues reveals some of the challenges clinicians face in the management of allergic diseases in the Indian subcontinent, especially with lack of availability of adrenaline auto-injectors, accessibility to validated in-vitro diagnostics, standardized allergens for skin testing and allergen immunotherapy products.